Paper41545296
Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis.
Myasoedova VA and 6 others. Open Heart, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis. Papers, record 41545296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aortic Valve Stenosis | Major topic |
| Aortic Valve | Major topic |
| Calcinosis | Major topic |
| Humans | |
| Prognosis | |
| Disease Progression | |
| Sclerosis | |
| Risk Factors | |
| Severity of Illness Index |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12505585 | Progression of aortic valve sclerosis to aortic stenosis. | Am J Cardiol | 2003 | https://conductscience.org/library/papers/12505585 | PubMed |
| 2 | 17185617 | Aortic valve calcification: determinants and progression in the population. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17185617 | PubMed |
| 3 | 37847155 | Outcomes of patients with early calcific aortic valve disease detected by clinically indicated echocardiography. | Eur Heart J Cardiovasc Imaging | 2024 | https://conductscience.org/library/papers/37847155 | PubMed |
| 4 | 30149054 | Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments. | Pharmacol Res | 2018 | https://conductscience.org/library/papers/30149054 | PubMed |
| 5 | 39985508 | Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. | JACC Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/39985508 | PubMed |
| 6 | 12418948 | The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. | Arch Intern Med | 2002 | https://conductscience.org/library/papers/12418948 | PubMed |
| 7 | 26198161 | Risk Stratification in Patients With Aortic Stenosis Using Novel Imaging Approaches. | Circ Cardiovasc Imaging | 2015 | https://conductscience.org/library/papers/26198161 | PubMed |
| 8 | 40343748 | Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. | Eur Heart J | 2025 | https://conductscience.org/library/papers/40343748 | PubMed |
| 9 | 34256259 | All-cause and cardiovascular mortality in patients undergoing hemodialysis with aortic sclerosis and mild-to-moderate aortic stenosis: A cohort study. | Atherosclerosis | 2021 | https://conductscience.org/library/papers/34256259 | PubMed |
| 10 | 29622430 | Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis. | Int J Cardiol | 2018 | https://conductscience.org/library/papers/29622430 | PubMed |
| 11 | 17996566 | Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. | J Am Coll Cardiol | 2007 | https://conductscience.org/library/papers/17996566 | PubMed |
| 12 | 39297852 | Deep Learning Model of Diastolic Dysfunction Risk Stratifies the Progression of Early-Stage Aortic Stenosis. | JACC Cardiovasc Imaging | 2025 | https://conductscience.org/library/papers/39297852 | PubMed |
| 13 | 39077564 | Echocardiographic Progression of Calcific Aortic Valve Disease in Patients with Preexisting Aortic Valve Sclerosis. | Rev Cardiovasc Med | 2023 | https://conductscience.org/library/papers/39077564 | PubMed |
| 14 | 22808835 | The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality. | J Heart Valve Dis | 2012 | https://conductscience.org/library/papers/22808835 | PubMed |
| 15 | 37529711 | Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37529711 | PubMed |
| 16 | 36822627 | Number of calcified aortic valve leaflets: natural history and prognostic value in patients undergoing haemodialysis. | Eur Heart J Cardiovasc Imaging | 2023 | https://conductscience.org/library/papers/36822627 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42384607 | Aortic Valve Sclerosis: More than an Incidental Echocardiographic Finding. | Cardiology | 2026 | https://conductscience.org/library/papers/42384607 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545296
GET https://conductscience.org/api/papers/v1/41545296/authors